Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma
- PMID: 22981791
- DOI: 10.1016/j.jaci.2012.08.005
Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma
Abstract
Background: Impaired immune response to viral infections in atopic asthmatic patients has been recently reported and debated. Whether this condition is present in childhood and whether it is affected by atopy per se deserves further investigation.
Objective: We sought to investigate airway interferon production in response to rhinovirus infection in children who are asthmatic, atopic, or both and its correlation with the airway inflammatory profile.
Methods: Bronchial biopsy specimens and epithelial cells were obtained from 47 children (mean age, 5 ± 0.5 years) undergoing bronchoscopy. The study population included asthmatic children who were either atopic or nonatopic, atopic children without asthma, and children without atopy or asthma. Rhinovirus type 16 induction of IFN-λ and IFN-β mRNA and protein levels was assessed in bronchial epithelial cell cultures. The immunoinflammatory profile was evaluated by means of immunohistochemistry in bronchial biopsy specimens.
Results: Rhinovirus type 16-induced interferon production was significantly reduced in atopic asthmatic, nonatopic asthmatic, and atopic nonasthmatic children compared with that seen in nonatopic nonasthmatic children (all P < .05). Increased rhinovirus viral RNA levels paralleled this deficient interferon induction. Additionally, IFN-λ and IFN-β induction correlated inversely with the airway T(H)2 immunopathologic profile (eosinophilia and IL-4 positivity: P < .05 and r = -0.38 and P < .05 and r = -0.58, respectively) and with epithelial damage (P < .05 and r = -0.55). Furthermore, total serum IgE levels correlated negatively with rhinovirus-induced IFN-λ mRNA levels (P < .05 and r = -0.41) and positively with rhinovirus viral RNA levels (P < .05 and r = 0.44).
Conclusions: Deficient interferon responses to rhinovirus infection are present in childhood in asthmatic subjects irrespective of their atopic status and in atopic patients without asthma. These findings suggest that deficient immune responses to viral infections are not limited to patients with atopic asthma but are present in those with other T(H)2-oriented conditions.
Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Comment in
-
Rhinovirus-induced asthma exacerbations during childhood: the importance of understanding the atopic status of the host.J Allergy Clin Immunol. 2012 Dec;130(6):1315-6. doi: 10.1016/j.jaci.2012.10.024. J Allergy Clin Immunol. 2012. PMID: 23195527 Free PMC article. No abstract available.
Similar articles
-
Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations.J Allergy Clin Immunol. 2019 Jan;143(1):114-125.e4. doi: 10.1016/j.jaci.2018.04.003. Epub 2018 Apr 24. J Allergy Clin Immunol. 2019. PMID: 29698627 Free PMC article. Clinical Trial.
-
Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons.J Allergy Clin Immunol. 2015 Jul;136(1):177-188.e11. doi: 10.1016/j.jaci.2014.11.039. Epub 2015 Jan 25. J Allergy Clin Immunol. 2015. PMID: 25630941 Free PMC article.
-
Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus.J Allergy Clin Immunol. 2011 May;127(5):1148-54.e9. doi: 10.1016/j.jaci.2011.01.023. Epub 2011 Feb 16. J Allergy Clin Immunol. 2011. PMID: 21329968
-
Human rhinoviruses, allergy, and asthma: a clinical approach.Medicina (Kaunas). 2009;45(11):839-47. Medicina (Kaunas). 2009. PMID: 20051716 Review.
-
Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma.Front Immunol. 2021 Nov 10;12:731807. doi: 10.3389/fimmu.2021.731807. eCollection 2021. Front Immunol. 2021. PMID: 34899691 Free PMC article. Review.
Cited by
-
Mechanical forces suppress antiviral innate immune responses from asthmatic airway epithelial cells following rhinovirus infection.Am J Physiol Lung Cell Mol Physiol. 2023 Aug 1;325(2):L206-L214. doi: 10.1152/ajplung.00074.2022. Epub 2023 Jun 6. Am J Physiol Lung Cell Mol Physiol. 2023. PMID: 37280545 Free PMC article.
-
Rhinovirus inhibits IL-17A and the downstream immune responses in allergic asthma.Mucosal Immunol. 2016 Sep;9(5):1183-92. doi: 10.1038/mi.2015.130. Epub 2016 Jan 6. Mucosal Immunol. 2016. PMID: 26732679 Free PMC article. Clinical Trial.
-
Anti-viral agents: potential utility in exacerbations of asthma.Curr Opin Pharmacol. 2013 Jun;13(3):331-6. doi: 10.1016/j.coph.2013.04.010. Epub 2013 May 9. Curr Opin Pharmacol. 2013. PMID: 23664758 Free PMC article. Review.
-
Rupintrivir reduces RV-induced TH-2 cytokine IL-4 in precision-cut lung slices (PCLS) of HDM-sensitized mice ex vivo.Respir Res. 2019 Oct 22;20(1):228. doi: 10.1186/s12931-019-1175-y. Respir Res. 2019. PMID: 31640701 Free PMC article.
-
Rhinovirus-Induced Cytokine Alterations With Potential Implications in Asthma Exacerbations: A Systematic Review and Meta-Analysis.Front Immunol. 2022 Feb 15;13:782936. doi: 10.3389/fimmu.2022.782936. eCollection 2022. Front Immunol. 2022. PMID: 35242128 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical